Background
In 2009, Fee-for-Service Medicare beneficiaries received in excess of 2 billion blood glucose test strips (Table 1 ). In the same year, the Advanced Medical Technology Association (AdvaMed) reported approximately 6.2 billon diabetes patient self-tests were performed, 2 suggesting that Medicare beneficiaries accounted for roughly a 30% share of the test strip market volume. In addition, 62% of test strips were provided to beneficiaries via mail from durable medical equipment (DME) distributors, while 38% of strips were obtained from retail locations. 3 In the 2008 to 2013 timeframe, the Centers for Medicare and Medicaid Services (CMS) intensified efforts to minimize waste, curb fraudulent claims, and reduce reimbursement rates: 
Historic Utilization
After anomalous double-digit growth in 2008, lower volume growth followed despite a relatively constant number of beneficiaries (Table 1) . 
